Supplementary Appendix 1 from Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
Authors:
- Ana OakninAOAna Oaknin
- Bhavana PothuriBPBhavana Pothuri
- Lucy GilbertLGLucy Gilbert
- Renaud SabatierRSRenaud Sabatier
- Jubilee BrownJBJubilee Brown
- Sharad GhamandeSGSharad Ghamande
- Cara MathewsCMCara Mathews
- David M. O'MAlleyDODavid M. O'MAlley
- Rebecca KristeleitRKRebecca Kristeleit
- Valentina BoniVBValentina Boni
- Adriano GravinaAGAdriano Gravina
- Susana BanerjeeSBSusana Banerjee
Open Access
- 16 September 2024
- other
- Published by American Association for Cancer Research (AACR)